Business

KKR : July 9, 2026 | KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

KKR : July 9, 2026 | KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision

Kkr & Co. Inc.July 9, 20263
KKR : July 9, 2026 | KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

About this update from Kkr & Co. Inc.

Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman NEW YORK-(BUSINESS WIRE)- KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR's existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra's growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707491568/en/ Robbie Atkinson will be appointed as Chief Executive Officer of Allyntra and Brian Highley as Chairman. Together, they bring deep experience building and scaling global manufacturing organizations through operational excellence and strategic leadership. Most recently, Mr. Atkinson served as CEO and President of Medical Manufacturing Technologies (MMT), where he led the company's strategy, operations, and growth through a period of significant expansion, culminating in its successful sale to Perimeter Solutions, Inc. (NYSE: PRM). Mr. Highley brings more than 30 years of experience across the medical technology industry, having previously served as CEO of Cirtec, where he scaled the company meaningfully from two sites into one of the leading providers of end-to-end services to medical technology OEMs, including design, engineering, prototyping, and manufacturing solutions. "The pace of innovation across medical technology and other highly engineered industries continues to accelerate," said Robbie Atkinson, Chief Executive Officer of Allyntra. "As these technologies become more sophisticated, customers are looking for partners who can help them move faster, solve increasingly complex challenges, and bring new ideas to life. That's exactly the opportunity I see for Allyntra." "Throughout my career, I've learned that the companies that endure are the ones that combine technical excellence with a willingness to continue evolving alongside their customers," said Brian Highley, Chairman of Allyntra. "Those are the qualities I believe will define Allyntra, ...

View stock analysis, news, and events for Kkr & Co. Inc.